
    
      Participants will receive 3 doses of either one of 4 different formulations of ACAM-CDIFF™
      vaccine or placebo, on one of 3 different schedules. The trial will have 2 stages. Stage I
      will test 4 different formulations of ACAM-CDIFF™ vaccine. Stage II will explore different
      vaccination schedules using one of these formulations.

      Participants will be followed up for safety and immunogenicity; stool samples will also be
      provided in case of diarrhea.
    
  